Neumora Therapeutics Inc. News
Latest updates and market news for NMRA
3 news
Dec 1 - Dec 7, 2025
Page 1
MT Newswires
RBC Upgrades Neumora Therapeutics to Outperform From Sector Perform, Raises Price Target to $7 From $4, Keeps Speculative Risk
📊
AI Sentiment
Positive
7/10
Share this news page